[(1S,2S)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]azanium | CAS:2964-48-9

We serve [(1S,2S)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]azanium CAS:2964-48-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
[(1S,2S)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]azanium

Chemical Name:[(1S,2S)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]azanium
CAS.NO:2964-48-9
Synonyms:[(1S,2S)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]azanium
(-)-(1R,2R)-1-para-nitrophenyl-2-amino-1,3-propanediol
L-(+)-threo-2-Amino-1-(4-nitrophenyl)-1,3-propanediol
(1S,2S)-2-Amino-1-(p-nitrophenyl)-1,3-propanediol
2-Amino-1-(4-nitrophenyl)-1,3-propanediol
2-amino-1-(4-nitrophenyl)propane-1,3-diol
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 451.9±45.0 °C at 760 mmHg
Melting Point 163-166ºC(lit.)
Molecular Formula C9H12N2O4
Molecular Weight 212.203
Flash Point 227.1±28.7 °C
Vapour Pressure 0.0±1.2 mmHg at 25°C
Index of Refraction 1.630
 
Specification:
Appearance:White to yellow crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Chloramphenicol(CAS:56-75-7).



Contact us for information like [(1S,2S)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]azanium chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-amino-1-(4-nitrophenyl)propane-1,3-diol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,L-(+)-threo-2-Amino-1-(4-nitrophenyl)-1,3-propanediol Use and application,(-)-(1R,2R)-1-para-nitrophenyl-2-amino-1,3-propanediol technical grade,usp/ep/jp grade.


Related News: From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats.Bromotris(dimethylamino)phosphonium hexafluorophosphate manufacturer Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.3-Bromo-2-chloropyridine supplier Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.3-Acetyl-5-chlorothiophene-2-sulfonamide vendor But many others apparently didn’t need confirmation. Posts on Weibo, China’s Twitter-like platform, purportedly showed people lining up at night outside pharmacies across China to buy Shuanghuanglian, ironically going against the authorities’ advice to avoid congregating in public.In order to seize the highest point of profits, international industry giants have adjusted their development strategies, concentrated their energies on the two ends of the smile curve-research and development and end products, and shifted production links such as intermediates and APIs outward. A division of labor model has been formed.